Classic view of this page
Myeloid Neoplasm Sequencing Panel V2.0
Clinical Genetic Test
Help
offered by
Tulane Hayward Genetics Center Molecular Diagnostics Lab
GTR Test Accession: Help GTR000597216.2
CAP
CANCERHEMATOLOGYIMMUNOLOGY ... View more
Last updated in GTR: 2021-12-09
View version history
Last annual review date for the lab: 2023-07-26 Past due LinkOut
At a Glance
Test purpose: Help
Diagnosis; Monitoring; Mutation Confirmation; ...
Conditions (4): Help
Acute myeloid leukemia; Myelodysplastic syndrome; Myeloid leukemia more...
Genes (1): Help
ABL1 (9q34.12)
Methods (1): Help
Molecular Genetics - Sequence analysis of select exons: Next-Generation (NGS)/Massively parallel sequencing (MPS)
Target population: Help
Not provided
Clinical validity: Help
Not provided
Clinical utility: Help
Not provided
Ordering Information
Offered by: Help
Tulane Hayward Genetics Center Molecular Diagnostics Lab
View lab's website
Test short name: Help
NGSHM
Manufacturer's name: Help
QIAseq, Thermofisher
Specimen Source: Help
Who can order: Help
  • Health Care Provider
Test Order Code: Help
Myeloid Neoplasm Sequencing Panel (NGS)
CPT codes: Help
**AMA CPT codes notice

Copyright: 2023 American Medical Association. All rights reserved.

Contact Policy: Help
Laboratory can only accept contact from health care providers. Patients/families are encouraged to discuss genetic testing options with their health care provider.
How to Order: Help
Please use the lab requisition form to order the test. If any questions, please contact the lab.
Order URL
Test service: Help
Clinical Testing/Confirmation of Mutations Identified Previously
Confirmation of research findings
Custom Deletion/Duplication Testing
Custom Sequence Analysis
Result interpretation
Test additional service: Help
Custom mutation-specific/Carrier testing
Test development: Help
Test developed by laboratory but exempt from FDA oversight (eg. NYS CLEP approved, offered within a hospital or clinic)
Informed consent required: Help
Decline to answer
Pre-test genetic counseling required: Help
No
Post-test genetic counseling required: Help
No
Recommended fields not provided:
Lab contact for this test, Test strategy
Conditions Help
Total conditions: 4
Condition/Phenotype Identifier
Test Targets
Genes Help
Total genes: 1
Gene Associated Condition Germline or Somatic Allele (Lab-provided) Variant in NCBI
Methodology
Total methods: 1
Method Category Help
Test method Help
Instrument *
Sequence analysis of select exons
Next-Generation (NGS)/Massively parallel sequencing (MPS)
* Instrument: Not provided
Clinical Information
Test purpose: Help
Diagnosis; Monitoring; Mutation Confirmation; Prognostic; Recurrence; Risk Assessment
Variant Interpretation:
Are family members with defined clinical status recruited to assess significance of VUS without charge? Help
Decline to answer.

Will the lab re-contact the ordering physician if variant interpretation changes? Help
Decline to answer.
Recommended fields not provided:
Clinical validity, Clinical utility, Target population, What is the protocol for interpreting a variation as a VUS?, Is research allowed on the sample after clinical testing is complete?, Sample negative report, Sample positive report
Technical Information
Test Comments: Help
Myeloid Neoplasm Sequencing Panel (NGS) Including ABL1 ASXL1 ATM ATRX BCOR BCORL1 BRAF CALR CBL CBLB CDKN2A CEBPA CSF3R DAXX DNMT3A EED EGFR ETV6 EZH2 FBXW7 FLT3 GATA1 GNAS HRAS IDH1 IDH2 IKZF1 JAK1 JAK2 JAK3 KAT6A KIT KMT2A KRAS MPL NF1 NOTCH1 NPM1 NRAS PDGFRA PHF6 PRPF40B PTEN PTPN11 … View more
Availability: Help
Tests performed
Entire test performed in-house
Analytical Validity: Help
This Myeloid NGS panel can provide: 1. For SNV: >99.9% confidence and 99.6% reliability for 100% sensitivity, specificity, and PPV 2. For Indels: 97.3% confidence and 97% reliability for 100% sensitivity, specificity, and PPV (excluding FLT3 ITD).
View citations (1)
  • Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists. Li MM, et al. J Mol Diagn. 2017;19(1):4-23. doi:10.1016/j.jmoldx.2016.10.002. PMID: 27993330.
Proficiency testing (PT):
Is proficiency testing performed for this test? Help
Yes

Method used for proficiency testing: Help
Formal PT program

PT Provider: Help
College of American Pathologists, CAP
Recommended fields not provided:
Test Confirmation, Assay limitations, Description of internal test validation method, Description of PT method, Major CAP category, CAP category, CAP test list
Regulatory Approval
FDA Review: Help
Not provided
Additional Information

IMPORTANT NOTE: NIH does not independently verify information submitted to GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.